MedPath

广东心宝药业科技有限公司

Ownership
-
Established
2010-01-13
Employees
-
Market Cap
-
Website
http://www.xinbao-pharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

NMPA:23

Drug Approvals

蒲地蓝消炎胶囊

Approval Number
国药准字Z20050027
Approval Date
Apr 26, 2024
NMPA

龟鹿补肾片

Approval Number
国药准字Z20080217
Approval Date
Nov 15, 2022
NMPA

柏子养心丸

Approval Number
国药准字Z14021120
Approval Date
Jun 23, 2021
NMPA

小儿咳喘灵颗粒

Approval Number
国药准字Z20053316
Approval Date
Jun 1, 2021
NMPA

明目地黄丸

Approval Number
国药准字Z14020915
Approval Date
Jan 25, 2021
NMPA

知柏地黄丸

Approval Number
国药准字Z14020921
Approval Date
Jan 11, 2021
NMPA

六味地黄丸

Approval Number
国药准字Z14020913
Approval Date
Jan 11, 2021
NMPA

橘红丸

Approval Number
国药准字Z14021127
Approval Date
Dec 31, 2020
NMPA

健脾丸

Approval Number
国药准字Z14021122
Approval Date
Dec 31, 2020
NMPA

杞菊地黄丸

Approval Number
国药准字Z14020923
Approval Date
Dec 31, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.